Rankings
▼
Calendar
AMRX Q1 2022 Earnings — Amneal Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
AMRX
Amneal Pharmaceuticals, Inc.
$4B
Q1 2022 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$498M
+0.9% YoY
Gross Profit
$175M
35.1% margin
Operating Income
$23M
4.7% margin
Net Income
-$2M
-0.4% margin
EPS (Diluted)
$-0.04
QoQ Revenue Growth
-7.3%
Cash Flow
Operating Cash Flow
$76M
Free Cash Flow
$66M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$3.9B
Total Liabilities
$3.5B
Stockholders' Equity
$391M
Cash & Equivalents
$210M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$498M
$493M
+0.9%
Gross Profit
$175M
$192M
-8.9%
Operating Income
$23M
$46M
-49.2%
Net Income
-$2M
$7M
-132.2%
Revenue Segments
Generics Segment
$318M
64%
Av K A R E Segment
$95M
19%
Amneal Specialty Pharma Segment
$85M
17%
← FY 2022
All Quarters
Q2 2022 →